Adagene Inc. (ADAG)
$2.74-0.72%Close
SELLCRISIS · day 8
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $103M
- Beta
- 0.56
- P/E (TTM)
- -6.21
- Short % float
- 7.83%
- Days to cover
- 7.5
- SI change
- +0.6%
- 1W
- -2.14%
- 1M
- -19.41%
- vs SPY 1W
- -2.56%
- vs SPY 1M
- -21.47%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on ADAG?
- LOPJLB’s latest quantitative signal on Adagene Inc. (ADAG) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is ADAG in?
- Adagene Inc. (ADAG) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Adagene Inc. (ADAG) do?
- Adagene Inc. functions as a clinical-stage biopharmaceutical organization, primarily concentrating on the identification, evolution, and fabrication of monoclonal antibody-based therapeutics engineered to combat various types of cancer. The company's developmental pipeline encompasses several investigational assets currently undergoing human trials. Among these is ADG106, a human ligand-blockin…